Immunotherapy
New Therapies
Immunotherapies shape the treatment landscape for hematologic malignancies
From the Journals
Groups release guidelines for CAR T treatment in children
Some of the tools used to detect toxicity that are used in older patients don’t work well in children.
From the Journals
Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitis
Melanoma patients who take higher doses of glucocorticoids for hypophysitis induced by the checkpoint-inhibitor also had a shorter time to...
Conference Coverage
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
AMSTERDAM –
New Therapies
Tumor heterogeneity: a central foe in the war on cancer
News
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
AMSTERDAM –
Latest News
MRD-negative status signals better outcomes in CAR T–treated ALL
CHICAGO – The study sheds light on the value of transplant after treatment with CAR T cells.
Conference Coverage
New ‘immune checkpoint’ vaccine shows promise in treating colorectal cancer
A vaccine may be a future treatment of colorectal cancer and is currently in phase 1 human trials.
From the Journals
Is cancer immunotherapy more effective in men than women?
Cancer immunotherapy with checkpoint inhibitors appears to achieve greater mortality reductions in men than in women, regardless of drug or cancer...
Conference Coverage
Low microbiota diversity linked to poor survival after transplant
SALT LAKE CITY - Lower calorie intake and exposure to broad-spectrum antibiotics were both associated with lower microbiota diversity.
Conference Coverage
Outpatient CAR T infusions feasible using liso-cel
SALT LAKE CITY – Though most patients are admitted later, hospital stays are shorter with outpatient CAR T infusion.